The Safety and Efficacy of Aspirin Discontinuation on a Background of a P2Y 12 Inhibitor in Patients After Percutaneous Coronary Intervention
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Safety and Efficacy of Aspirin Discontinuation on a Background of a P2Y
12
Inhibitor in Patients After Percutaneous Coronary Intervention
Authors
Keywords
-
Journal
CIRCULATION
Volume 142, Issue 6, Pages 538-545
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2020-06-19
DOI
10.1161/circulationaha.120.046251
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation
- (2019) Renato D. Lopes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention
- (2019) Joo-Yong Hahn et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
- (2019) Hirotoshi Watanabe et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
- (2019) Renato D. Lopes et al. JAMA Cardiology
- Ticagrelor with or without Aspirin in High-Risk Patients after PCI
- (2019) Roxana Mehran et al. NEW ENGLAND JOURNAL OF MEDICINE
- RoB 2: a revised tool for assessing risk of bias in randomised trials
- (2019) Jonathan A C Sterne et al. BMJ-British Medical Journal
- Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes
- (2019) Mariusz Tomaniak et al. JAMA Cardiology
- Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting
- (2019) Anna Franzone et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
- (2018) Pascal Vranckx et al. LANCET
- Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack
- (2016) S. Claiborne Johnston et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
- (2016) C. Michael Gibson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation
- (2015) Katrin A. Fiedler et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
- (2014) Laura Mauri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial
- (2013) Willem JM Dewilde et al. LANCET
- Standardized Bleeding Definitions for Cardiovascular Clinical Trials
- (2011) Roxana Mehran et al. CIRCULATION
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytochrome P-450 Polymorphisms and Response to Clopidogrel
- (2008) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now